Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002054

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Geffken Daniel E. CHIEF FINANCIAL OFFICER 2021-04-20 Grant or award · Non-Qualified Stock Option (right to buy) +100,000 100,000 D: show line 1 in the form
Loading xslF345X03/form4-04222021_110401.xml…